BioSpace News Archive

Bio-Path Holdings, Inc. announced that the U.S. Food and Drug Administration has reviewed and cleared the Investigational New Drug application for BP1002, the Company’s second drug candidate, for an initial Phase 1/ 1b clinical trial that will evaluate the ability of BP1002 to treat refractory/relapsed acute myeloid leukemia patients.

Nitinol stent is a small tube of mesh made of nitinol material, which is used for the treatment of narrowed and weakened arteries or veins

Pleural effusion is a condition that causes the accumulation of an unusual amount of fluid around the lungs.

Mast cell tumor refers to a type of cancer of blood cell, which is normally engaged with the response of the body to inflammation and allergens.

The laser therapy devices market is extrapolated to observe considerable growth across the forecast period of 2019-2028.

The reports at TMR Research provide qualitative solutions that break the barriers of doubt or uncertainties when the stakeholders plan to expand their growth reach.

The allergy care market may bring good growth opportunities across the forecast period of 2019-2028.

Kintor Pharmaceutical Limited, a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, announced the company will review the interim results and business highlights on Monday, August 30,2021.

ImmuCell Corporation today announced that the FDA has issued a Technical Section Incomplete Letter covering the Chemistry, Manufacturing and Controls (CMC) Technical Section for Re-Tain

Global health services company Cigna Corporation will repurchase $2.0 billion of common stock through accelerated stock repurchase agreements with each of Morgan Stanley & Co. LLC and JPMorgan Chase Bank, N.A.